menu
    • menu
    [{"orgOrder":0,"company":"Step Pharma","sponsor":"V-Bio Ventures | Pontifax | Bpifrance| Kurma Partners| Hadean Ventures | Sunstone Life Science Ventures| Inserm Transfert Initiative","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"FRANCE","productType":"Miscellaneous","year":"2025","type":"Series C Financing","leadProduct":"Dencatistat","moa":"CTPS1","graph1":"Oncology","graph2":"Phase I\/ Phase II","graph3":"Step Pharma","amount2":0.040000000000000001,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Oncology","amount2New":0.040000000000000001,"dosageForm":"Capsule","sponsorNew":"Step Pharma \/ V-Bio Ventures | Pontifax | Bpifrance| Kurma Partners| Hadean Ventures | Sunstone Life Science Ventures| Inserm Transfert Initiative","highestDevelopmentStatusID":"7","companyTruncated":"Step Pharma \/ V-Bio Ventures | Pontifax | Bpifrance| Kurma Partners| Hadean Ventures | Sunstone Life Science Ventures| Inserm Transfert Initiative"}]

    Find Clinical Drug Pipeline Developments & Deals for Dencatistat

    Menu

    Dencatistat

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Step Pharma

                            France arrow
                            AAPS
                            Not Confirmed

                            Step Pharma

                            France arrow
                            AAPS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Dencatistat

                            Therapeutic Area : Oncology

                            Study Phase : Phase I/ Phase II

                            Sponsor : V-Bio Ventures | Pontifax | Bpifrance| Kurma Partners| Hadean Ventures | Sunstone Life Science Ventures| Inserm Transfert Initiative

                            Deal Size : $44.2 million

                            Deal Type : Series C Financing

                            DEALS_DEV arrow-down

                            Step Pharma Completes €38M Series C Financing

                            Details : The Series C financing will support the development of a lead product targeting CTPS1 in essential thrombocythaemia.

                            Product Name : STP938

                            Product Type : Miscellaneous

                            Upfront Cash : Undisclosed

                            October 15, 2025

                            Lead Product(s) : Dencatistat

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase I/ Phase II

                            Sponsor : V-Bio Ventures | Pontifax | Bpifrance| Kurma Partners| Hadean Ventures | Sunstone Life Science Ventures| Inserm Transfert Initiative

                            Deal Size : $44.2 million

                            Deal Type : Series C Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth